Company: BSX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000885725-25-000050
Chunk: 142

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 8
Chunk 142
---
oring ArrangementsAs of September 30, 2025As of December 31, 2024AmountDe-recognizedWeighted AverageInterest RateAmountDe-recognizedWeighted AverageInterest RateEuro denominated$189 3.5 %$176 5.3 %Yen denominated226 1.3 %193 0.9 %Renminbi denominated13 1.8 %26 2.0 %Other Contractual Obligations and CommitmentsWe had outstanding letters of credit of $223 million as of September 30, 2025 and $206 million as of December 31, 2024, which consisted primarily of bank guarantees and collateral for workers' compensation insurance arrangements. As of September 30, 2025 and December 31, 2024 we had not recognized a related liability for our outstanding letters of credit within our accompanying unaudited consolidated balance sheets.We have a supplier financing program offered primarily in the U.S. that enables our suppliers to opt to receive early payment at a nominal discount, while allowing us to lengthen our payment terms and optimize working capital. Our standard payment term in the U.S. is 90 days. All outstanding payables related to the supplier finance program are classified within Accounts Payable within our unaudited consolidated balance sheets and were $151 million as of September 30, 2025 and $140 million as of December 31, 2024.Refer to Note E – Contractual Obligations and Commitments to our audited financial statements contained in Item 8. Financial Statements and Supplementary Data of our most recent Annual Report on Form 10-K for additional information on our borrowings and credit agreements.LeasesIn the third quarter of 2025, we commenced a previously executed lease agreement for additional office and lab space in Maple Grove, Minnesota. The lease was classified as a finance lease, resulting in the recognition of a right-of-use asset of approximately $268 million and a corresponding lease liability of approximately $195 million as of September 30, 2025. The right-of-use asset is included within Property, plant and equipment, net, and the related lease liability is included within Current debt obligations within our accompanying unaudited consolidated balance sheets. The lease has a non-cancellable term of 20 years and includes a buyout option that is currently exercisable. We are reasonably certain we will exercise this option in the fourth quarter of 2025.

NOTE F – SUPPLEMENTAL BALANCE